Pricing

Abeona Therapeutics Inc (ABEO)

followers ·
Sector:
HEALTH CARE
Industry:
PHARMACEUTICALS
SIC:
PHARMACEUTICAL PREPARATIONS
CEO:
Vishwas Seshadri
Employees:
90
6555 CARNEGIE AVE, 4TH FLOOR, CLEVELAND, OH, 44103
646-813-4701
    Formally known as:
  • Access Pharmaceuticals Inc
  • Access Pharmaceuticals Inc.
  • PLASMATECH BIOPHARMACEUTICALS,
Stock Split History
DateRatio
2006-06-05 0.2000
2014-10-24 1:50
2022-07-05 1:25
Abeona Therapeutics Inc. develops gene and cell therapies for life-threatening rare genetic diseases. Its lead program is EB-101, an autologous, gene-corrected cell therapy that is in Phase III clinical trial for recessive dystrophic epidermolysis bullosa. The company also develops ABO-102, an adeno-associated virus (AAV)-based gene therapy for Sanfilippo syndrome type A.
All 13F Filers Prior Change Hedge Funds 1 Prior Change
InvestorHistoryShares Held or Principal AmtMarket Value% of PortfolioPrevious % of PortfolioRankChange in Shares% OwnershipQtr 1st OwnedEst. Avg PriceSourceSource DateDate Reported
No data available